T1	intervention 30 51	Calendula officinalis
T2	control 66 75	trolamine
T3	condition 98 114	acute dermatitis
T4	location 452 458	France
T6	total-participants 625 628	254
T7	control-participants 797 800	128
T8	intervention-participants 825 828	126
T9	outcome-Measure 914 965	occurrence of acute dermatitis of grade 2 or higher
T10	outcome-Measure 1101 1119	occurrence of pain
T11	outcome-Measure 1125 1155	quantity of topical agent used
T12	outcome-Measure 1161 1181	patient satisfaction
T13	outcome 1187 1238	occurrence of acute dermatitis of grade 2 or higher
T14	iv-bin-percent 1264 1267	41%
T15	cv-bin-percent 1270 1273	63%
T18	eligibility 629 736	patients who had been operated on for breast cancer and who were to receive postoperative radiation therapy
T16	outcome 1443 1465	radiation-induced pain
T17	outcome 1527 1553	self-assessed satisfaction
